These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 17907761

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M, Khanthavong M, Lindegårdh N, Keola S, Barends M, Pongvongsa T, Yapom R, Annerberg A, Phompida S, Phetsouvanh R, White NJ, Newton PN.
    Clin Infect Dis; 2004 Oct 15; 39(8):1139-47. PubMed ID: 15486837
    [Abstract] [Full Text] [Related]

  • 3. Poor knowledge on new malaria treatment guidelines among drug dispensers in private pharmacies in Tanzania: the need for involving the private sector in policy preparations and implementation.
    Minzi OM, Haule AF.
    East Afr J Public Health; 2008 Aug 15; 5(2):117-21. PubMed ID: 19024421
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
    van den Broek IV, Maung UA, Peters A, Liem L, Kamal M, Rahman M, Rahman MR, Bangali AM, Das S, Barends M, Faiz AM.
    Trans R Soc Trop Med Hyg; 2005 Oct 15; 99(10):727-35. PubMed ID: 16095643
    [Abstract] [Full Text] [Related]

  • 5. How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy.
    Nsimba SE.
    J Ethnobiol Ethnomed; 2006 Jan 10; 2():5. PubMed ID: 16403225
    [Abstract] [Full Text] [Related]

  • 6. Impact of delayed introduction of sulfadoxine-pyrimethamine and arthemeter-lumefantrine on malaria epidemiology in KwaZulu-Natal, South Africa.
    Knight SE, Anyachebelu EJ, Geddes R, Maharaj R.
    Trop Med Int Health; 2009 Sep 10; 14(9):1086-92. PubMed ID: 19624481
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
    Tall A, Rabarijaona LP, Robert V, Bedja SA, Ariey F, Randrianarivelojosia M.
    Acta Trop; 2007 Jun 10; 102(3):176-81. PubMed ID: 17568549
    [Abstract] [Full Text] [Related]

  • 8. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B, Baea K, Lorry K, Ginny M, Wines B, Alpers MP.
    P N G Med J; 2005 Jun 10; 48(3-4):141-50. PubMed ID: 17212060
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of monotherapies and artesunate-based combination therapies in children with uncomplicated malaria in Somalia.
    Warsame M, Atta H, Klena JD, Waqar BA, Elmi HH, Jibril AM, Hassan HM, Hassan AM.
    Acta Trop; 2009 Feb 10; 109(2):146-51. PubMed ID: 19026606
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine-pyrimethamine combination in Central African children with noncomplicated malaria.
    Menard D, Madji N, Manirakiza A, Djalle D, Koula MR, Talarmin A.
    Am J Trop Med Hyg; 2005 May 10; 72(5):581-5. PubMed ID: 15940847
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K, Durrani N, Rahim S, Rowland M.
    Trans R Soc Trop Med Hyg; 2007 Nov 10; 101(11):1081-7. PubMed ID: 17707447
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J, Müeller I, Sie A, Maku P, Goroti M, Reeder JC, Beck HP, Genton B.
    Am J Trop Med Hyg; 2007 Nov 10; 77(5):947-54. PubMed ID: 17984359
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I, Dorsey G, Rouamba N, Dokomajilar C, Séré Y, Rosenthal PJ, Ouédraogo JB.
    Clin Infect Dis; 2007 Dec 01; 45(11):1453-61. PubMed ID: 17990228
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.